Bevacizumab and AZD2171 in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma

This study is currently recruiting participants.

Study NCT00458731 Information provided by National Cancer Institute (NCI)

First Received: April 9, 2007 Last Updated: June 27, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	October 2008 (Final data collection date for primary outcome measure)